Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evaxion Biotech A/S

1.86
+0.01000.54%
Post-market: 1.920.0599+3.22%18:11 EDT
Volume:16.23K
Turnover:30.48K
Market Cap:11.66M
PE:-0.10
High:1.92
Open:1.92
Low:1.85
Close:1.85
Loading ...
Jan 29, 2025

Correspondence

Form CORRESP - Correspondence
Jan 28, 2025

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Dec 18, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Dec 05, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Nov 18, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 20, 2024

Correspondence

Form CORRESP - Correspondence
Aug 20, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Jul 22, 2024

Correspondence

Form CORRESP - Correspondence
Jul 22, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
May 06, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Mar 26, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jan 31, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Jan 31, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Jan 30, 2024

Correspondence

Form CORRESP - Correspondence